Pillstats
Rx only · Tablet, Coated · Oral

Olmesartan Medoxomil

Olmesartan Medoxomil

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US27 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)118463
US makers9 labelers
Packages76
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.025$0.051$0.076$0.101Dec 2025Apr 2026Jul 2026
$0.085
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
9
Active US suppliers
36%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10K20K30K41K2025 Q12025 Q22025 Q32025 Q42026 Q1
35K
Rx · 2026 Q1
1.8M
Units dispensed
+20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Ascend Laboratories, LLCunknown16SUPPLYING
Inventia Healthcare Limitedunknown11SUPPLYING
Modavar Pharmaceuticals LLCunknown10SUPPLYING
Cadila Pharmaceuticals Limitedunknown10SUPPLYING
Bryant Ranch Prepackrepackager10SUPPLYING
A-S Medication Solutionsunknown6SUPPLYING
Rising Pharma Holdings, Inc.unknown6SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Proficient Rx LPunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 29, 2021
    RECALLRecall (Class III): Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013.…

    Presence of Foreign Tablet/Capsule — Recalling firm: Ascend Laboratories LLC — Nationwide

  • Jan 24, 2020
    RECALLRecall (Class II): Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - …

    cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement. — Recalling firm: Ascend Laboratories LLC — Nationwide in the U.S.